Integra LifeSciences Reports First Quarter 2026 Financial Results
Integra LifeSciences reported solid financial results for Q1 2026 with revenues increasing 2.4% to $391.9 million, adjusted earnings per diluted share improving to $0.54 from $0.41 year-over-year, and affirmed full year 2026 revenue guidance while raising adjusted EPS guidance to $2.40-$2.50. The company highlighted operational improvements includi…